Iglim MV 2 mg/500 mg/0.2 mg Tablet
By Iglim MV
Rx
10 Tablet in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Emenox Healthcare
Premises Nos. 1 to 8, 1st Floor, " Ratna Umed Residency ", Above Union Bank of India, Plot No.117, Umed Nagar, Louis Wadi, Thane.(w) 400604., Taluka and District – Thane, MUMBAI

Expires on or after
October, 2025

liver
When using Iglim MV 2 mg/500 mg/0.2 mg Tablet, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dosage accordingly, so it's best to consult with them before starting this medication. Typically, Rozmet Trio is initiated at a low dose for individuals with mild to moderate liver issues. However, it is not advisable to use this tablet if you have severe liver disease. If you have any concerns or liver-related issues, it's crucial to seek guidance from your healthcare provider before taking Iglim MV 2 mg/500 mg/0.2 mg Tablet.

kidney
Iglim MV 2 mg/500 mg/0.2 mg Tablet should be avoided if you have kidney disease. Consult your doctor before use. Not recommended for severe kidney disease.

alcohol
Avoid consuming alcohol while taking Iglim MV 2 mg/500 mg/0.2 mg Tablet.

driving
Avoid driving if you experience symptoms of low or high blood sugar while taking Iglim MV 2 mg/500 mg/0.2 mg Tablet, as it may affect your ability to drive safely.

pregnancy
Iglim MV 2 mg/500 mg/0.2 mg Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will assess risks versus benefits before prescribing. Consult your doctor before use.

breastfeeding
Iglim MV 2 mg/500 mg/0.2 mg Tablet is likely unsafe while breastfeeding. Limited data indicates the drug can pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹100
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024